Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1825 1
1925 2
1926 4
1927 1
1928 1
1929 1
1930 4
1931 3
1932 1
1933 4
1935 2
1936 1
1937 1
1938 2
1939 2
1940 1
1942 2
1945 2
1946 13
1947 11
1948 8
1949 3
1950 7
1951 12
1952 14
1953 12
1954 15
1955 10
1956 14
1957 7
1958 13
1959 19
1960 18
1961 17
1962 24
1963 13
1964 31
1965 15
1966 21
1967 19
1968 19
1969 17
1970 17
1971 21
1972 16
1973 19
1974 31
1975 21
1976 20
1977 22
1978 18
1979 14
1980 20
1981 26
1982 28
1983 26
1984 19
1985 35
1986 33
1987 53
1988 55
1989 80
1990 71
1991 90
1992 95
1993 110
1994 110
1995 115
1996 138
1997 134
1998 128
1999 156
2000 144
2001 155
2002 161
2003 184
2004 202
2005 198
2006 193
2007 235
2008 250
2009 231
2010 306
2011 331
2012 309
2013 328
2014 481
2015 535
2016 513
2017 521
2018 531
2019 571
2020 627
2021 699
2022 670
2023 605
2024 282

Text availability

Article attribute

Article type

Publication date

Search Results

10,234 results

Results by year

Filters applied: . Clear all
Page 1
Magee equations and oncotype DX()-a perspective.
Bhargava R, Dabbs DJ. Bhargava R, et al. Breast Cancer Res Treat. 2017 Jul;164(1):245-246. doi: 10.1007/s10549-017-4235-3. Epub 2017 Apr 9. Breast Cancer Res Treat. 2017. PMID: 28393310 No abstract available.
Reply.
Magee GA. Magee GA. J Vasc Surg. 2018 Jun;67(6):1940-1941. doi: 10.1016/j.jvs.2018.03.398. J Vasc Surg. 2018. PMID: 29801562 Free article. No abstract available.
The Story of the Magee Equations: The Ultimate in Applied Immunohistochemistry.
Bhargava R, Dabbs DJ. Bhargava R, et al. Appl Immunohistochem Mol Morphol. 2023 Aug 1;31(7):490-499. doi: 10.1097/PAI.0000000000001065. Epub 2022 Sep 21. Appl Immunohistochem Mol Morphol. 2023. PMID: 36165933 Free PMC article.
Magee equations (MEs) are a set of multivariable models that were developed to estimate the actual Onco type DX (ODX) recurrence score in invasive breast cancer. ...The new cut-off for ODX recurrence score, as reported in the Trial Assigning IndividuaLized Options for Trea …
Magee equations (MEs) are a set of multivariable models that were developed to estimate the actual Onco type DX (ODX) recurrence scor …
Preeclampsia. Reply.
Magee LA, Nicolaides KH, von Dadelszen P. Magee LA, et al. N Engl J Med. 2022 Jul 21;387(3):287. doi: 10.1056/NEJMc2207559. N Engl J Med. 2022. PMID: 35857677 No abstract available.
Reply.
O'Banion LA, Magee GA. O'Banion LA, et al. J Vasc Surg. 2022 Feb;75(2):771. doi: 10.1016/j.jvs.2021.11.054. J Vasc Surg. 2022. PMID: 35067333 Free article. No abstract available.
Reply.
Magee GA, O'Banion LA. Magee GA, et al. J Vasc Surg. 2022 Apr;75(4):1496. doi: 10.1016/j.jvs.2021.11.068. Epub 2021 Dec 16. J Vasc Surg. 2022. PMID: 34921968 Free article. No abstract available.
Single cell heterogeneity and evolution of breast cancer bone metastasis and organoids reveals therapeutic targets for precision medicine.
Ding K, Chen F, Priedigkeit N, Brown DD, Weiss K, Watters R, Levine KM, Heim T, Li W, Hooda J, Lucas PC, Atkinson JM, Oesterreich S, Lee AV. Ding K, et al. Ann Oncol. 2022 Oct;33(10):1085-1088. doi: 10.1016/j.annonc.2022.06.005. Epub 2022 Jun 25. Ann Oncol. 2022. PMID: 35764274 Free PMC article. No abstract available.
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors.
Farrugia DJ, Landmann A, Zhu L, Diego EJ, Johnson RR, Bonaventura M, Soran A, Dabbs DJ, Clark BZ, Puhalla SL, Jankowitz RC, Brufsky AM, Lembersky BC, Ahrendt GM, McAuliffe PF, Bhargava R. Farrugia DJ, et al. Mod Pathol. 2017 Aug;30(8):1078-1085. doi: 10.1038/modpathol.2017.41. Epub 2017 May 26. Mod Pathol. 2017. PMID: 28548119 Free article.
Magee Equations were derived as an inexpensive, rapid alternative to Oncotype DX. ...The pathologic complete response rate for low, intermediate and high Magee Equation 3 scores was 0%, 4%, and 36%, respectively. Patients with high Magee Equation 3 scores wer …
Magee Equations were derived as an inexpensive, rapid alternative to Oncotype DX. ...The pathologic complete response rate for low, i …
Tumor-Infiltrating Lymphocytes Improve Magee Equation-Based Prediction of Pathologic Complete Response in HR-Positive/HER2-Negative Breast Cancer.
Li F, Zhao Y, Wei Y, Xi Y, Bu H. Li F, et al. Am J Clin Pathol. 2022 Aug 4;158(2):291-299. doi: 10.1093/ajcp/aqac041. Am J Clin Pathol. 2022. PMID: 35486808
OBJECTIVES: Magee equation 3 (ME3) is predictive of the pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer but with insufficient predic …
OBJECTIVES: Magee equation 3 (ME3) is predictive of the pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in patie …
Reply.
O'Banion LA, Magee GA. O'Banion LA, et al. J Vasc Surg. 2021 Sep;74(3):1051. doi: 10.1016/j.jvs.2021.05.010. J Vasc Surg. 2021. PMID: 34425951 Free article. No abstract available.
10,234 results
You have reached the last available page of results. Please see the User Guide for more information.